Curis Q1 2006 Financial Results
Curis, who in March reached a development milestone for a hair loss treatment, released their financial results for the first quarter of 2006.
For the first quarter of 2006, Curis reported a net loss of $4,049,000, or ($0.08) per share, as compared to a net loss of $5,381,000 or ($0.11) per share for the same period in the prior year.
Net revenues for the first quarter of 2006 were $2,038,000 as compared to ($813,000) for the first quarter of 2005, an increase of $2,851,000. The increase in net revenues was primarily due to a decrease in contra-revenues recorded under the Company’s basal cell carcinoma co-development arrangement with Genentech (NYSE: DNA).
Go here for more complete details.
Technorati Tags: Curis
Related Stories
POSTED IN: Bald Medicine
.gif)
0 opinions for Curis Q1 2006 Financial Results
No one has left a comment yet. You know what this means, right? You could be first!
Have an opinion? Leave a comment: